glucagon agonist retatrutide triple gip glp-1 phase 3 2025 Dual and Gut Peptide Agonists on the Horizon for the Treatment of Type 2 Diabetes and GLP-3 (R)

Acute pancreatitis can cause severe upper abdominal pain, persistent vomiting, fever, elevated pancreatic enzymes, tissue necrosis, infection, and, in severe cases, organ failure requiring intensive medical treatment

First: plan for long-term, possibly lifelong therapy

When comparing semaglutide versus Ozempic pen, its important to understand that Ozempic specifically uses semaglutide to help control blood sugar in adults with type 2 diabetes

First, SELECT was designed as a CV outcomes trial and not a weight-loss trial, and weight loss was only a supportive secondary endpoint in the trial design

Many people are surprised to hear that we naturally make GLP-1 on our own

ZepBound, launched for obesity in late 2023, quickly added hundreds of millions in sales by mid-2025, its global sales were already in the hundreds of millions as clinics rolled out the new weight-loss injection